MFORMATION TECHNOLOGIES, INC., Plaintiff, v. RESEARCH IN MOTION LIMITED and Research in Motion Corporation, Defendants No. C08–04990 JW (HRL) United States District Court, N.D. California, San Jose Division August 09, 2010 Counsel Shawn Edward McDonald, Amardeep Lal Thakur, Foley & Lardner LLP, San Diego, CA, Gina Ann Bibby, Foley & Lardner LLP, Palo Alto, CA, Justin E. Gray, Foley & Lardner LLP, Madison, WI, for Plaintiff. Aaron D. Charfoos, Carl John Blickle, Eugene Goryunov, Linda S. Debruin, Maria A. Maras, Meredith Zinanni, Michael Anthony Parks, Kirkland & Ellis, LLP, Chicago, IL, Bradford John Black, Kirkland & Ellis LLP, San Francisco, CA, Marc Howard Cohen, Kirkland & Ellis LLP, Los Angeles, CA, for Defendants. Lloyd, Howard R., United States Magistrate Judge ORDER GRANTING IN PART AND DENYING IN PART PLAINTIFF'S MOTION TO (1) COMPEL DEPOSITIONS AND (2) DE–DESIGNATE EMAILS *1 Plaintiff Mformation Technologies, Inc. (Mformation) moves for an order (1) compelling defendants Research in Motion Limited and Research in Motion Corporation (collectively, RIM) to produce their co-Chief Executive Officers Jim Basillie and Mike Lazaridis for deposition; and (2) de-designating certain emails that RIM has designated “Confidential–Attorneys' Eyes Only.” RIM opposes the motion. Upon consideration of the moving and responding papers, as well as the arguments of counsel, this court grants the motion in part and denies it in part. A. Motion to Compel Basillie and Lazaridis Depositions Mformation wants to depose Basillie and Lazaridis with respect to the parties' prior business negotiations, as well as certain statements re Mformation and its technology made by Basillie and Lazaridis during the course of those negotiations. RIM contends that Basillie and Lazaridis are busy executives who have no unique or superior knowledge about facts at issue in this litigation. “A party seeking to prevent a deposition carries a heavy burden to show why discovery should be denied.” Websidestory, Inc. v. Netratings, Inc., C06cv408, 2007 WL 1120567 *2 (S.D.Cal., Apr.6, 2007). When a party seeks the deposition of a high-level executive (a so-called “apex” deposition), the court may exercise its discretion under the federal rules to limit discovery. See id.; FED. R. CIV. P. 26(b)(1)-(b)(2). In determining whether to allow an apex deposition, courts consider (1) whether the deponent has unique first-hand, non-repetitive knowledge of facts at issue in the case and (2) whether the party seeking the deposition has exhausted other less intrusive discovery methods. Websidestory, Inc., 2007 WL 1120567 at *2. Absent extraordinary circumstances, it is very unusual for a court to prohibit the taking of a deposition. Id. Additionally, “when a witness has personal knowledge of facts relevant to the lawsuit, even a corporate president or CEO is subject to deposition.” Id. A claimed lack of knowledge, by itself, is insufficient to preclude a deposition. Id. “Moreover, the fact that the apex witness has a busy schedule is simply not a basis for foreclosing otherwise proper discovery.” Id. The parties' prior (and ultimately, unsuccessful) business negotiations took place years before the U.S. Patent No. 6,970,917 issued.[1] Nevertheless, under Fed.R.Civ.P. 26's broad standard of relevance, the discovery sought is relevant or reasonably calculated to lead to the discovery of admissible evidence of, for example, RIM's knowledge re Mformation and its technology. As for Basillie's and Lazaridis' roles in those negotiations, they apparently briefly met or spoke with Mformation's CEO on one or two occasions during those negotiations. But the record indicates that, for the most part, Basillie and Lazaridis were not actual participants in those negotiations, and instead supervised others who dealt directly with Mformation. Mformation says that it has not been able to obtain the subject discovery through other means, such as RIM's Fed.R.Civ.P. 30(b)(6) deposition. However, RIM says that it has designated David Castell—who apparently had a hands-on role in the parties' prior business negotiations—to testify about RIM's knowledge of Mformation and its technology, but Mformation simply has not gotten around to deposing Castell. (Indeed, this court is told that, after having turned down RIM's proposed May and June 2010 deposition dates, Mformation has agreed to depose Castell on September 15–16, 2010). *2 Nevertheless, Basillie and Lazaridis did make certain statements about Mformation and its technology. Mformation says that it has, so far, been unsuccessful in obtaining testimony from others about those statements; and indeed, plaintiff says that others will probably not be able to testify about them. Although the parties sharply disagree as to the import of those statements, this court will permit Mformation to conduct a limited deposition of Basillie and of Lazaridis. However, to alleviate the burden on Basillie and Lazaridis, Mformation shall first complete its examination of Castell in his capacity as RIM's Fed.R.Civ.P. 30(b)(6) designee. Additionally, the depositions of Basillie and Lazaridis shall be limited to one hour each. B. Motion to De–Designate Three Emails The three email strings at issue are appended as Exhibits A, B and C to the Thakur Declaration. They contain messages exchanged between Basillie, Lazaridis and Castell re Mformation during the prior Mformation–RIM business negotiations. RIM has designated them “Confidential–Attorneys' Eyes Only.” Claiming that the emails contain no confidential information whatsoever, Mformation argues that they should be de-designated entirely. Neither side's arguments are very compelling. The emails do not appear to be public information, and this court declines to de-designate them entirely, as Mformation requests. However, this court sees no basis for the “Attorneys' Eyes Only” designation; and, it finds that a “Confidential” designation should suffice. RIM confirmed the same at the hearing. Accordingly, the emails in question shall be de-designated “Confidential” under the parties' stipulated protective order (Docket No. 51). SO ORDERED. Footnotes [1] Discovery as to the other patent-in-suit, U.S. Patent No. 7,343,408, has been stayed.